STOCK OPTIONS

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

NOTE 4 - STOCK OPTIONS

1. The following table presents the Company’s stock option activity during the three months ended March 31, 2024:

SCHEDULE OF STOCK OPTION ACTIVITY

	Number of Options		Weighted Average Exercise Price
Outstanding at December 31,2023		36,602,000,000		0.001
Granted		-		-
Exercised		-		-
Forfeited or expired		-		-
Outstanding at March 31,2024		36,602,000,000		0.001
Number of options exercisable at March 31, 2024		14,000,000,000		0.001

The aggregate intrinsic value of the awards outstanding as of March 31, 2024 is 3,660,200. These amounts represent the total intrinsic value, based on the Company’s stock price of $0.0002 as of March 31, 2024, less the weighted exercise price. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

The stock options outstanding as of March 31, 2024, have been separated into exercise prices, as follows:

Exercise price	Stock options outstanding		Weighted average remaining contractual life – years		Stock options vested
	As of March 31, 2024
0.001		36,602,000,000		2.50		14,000,000,000
		36,602,000,000		2.50		14,000,000,000

The stock options outstanding as of March 31, 2023, have been separated into exercise prices, as follows:

Exercise price	Stock options outstanding		Weighted average remaining contractual life – years		Stock options vested
	As of March 31, 2023
0.001		46,602,000,000		3.50		9,600,000,000
		46,602,000,000		3.50		9,600,000,000

Compensation expense recorded by the Company in respect of its stock-based compensation awards for the three months ended March 31, 2024 and 2023 was $972,750 and $2,219,109, respectively and are included in the Statements of Operations.

As of March 31, 2024, the total share-based compensation costs not yet recognized related to unvested stock options was $3,315,588 million, which is expected to be recognized over the weighted-average remaining requisite service period of 1.39 years.

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

WORLD HEALTH ENERGY HOLDINGS, INC. 10-Q